生物活性

• 描述Dexelvucitabine is a nucleoside reverse transcriptase inhibitor potentially for the treatment of HIV infection.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT00040157	HIV Infections	Phase 2	Terminated(Safety concerns)	-	United States, Arizona ... more >> Body Positive, Inc. Phoenix, Arizona, United States, 85006 United States, California L.a., California, United States Pacific Horizon Medical Group, Inc. San Francisco, California, United States, 94115 United States, Florida Community Health Care Center One, Inc. Ft. Lauderdale, Florida, United States, 33306 South Shore Hospital Miami Beach, Florida, United States, 33160 United States, Georgia AIDS Research Consortium Atlanta, Georgia, United States, 30308 United States, Illinois Chicago, Illinois, United States United States, New York St. Lukes Roosevelt Hospital New York, New York, United States, 10019 Stony Brook University Infectious Disease, Dept. of Medicine Stony Brook, New York, United States, 11794-8153 United States, Texas Houston, Texas, United States, 77098 Houston, Texas, United States United States, Virginia Hampton Road Medical Specialists Hampton, Virginia, United States, 23666 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98122 Collapse <<
  NCT00037622	Chronic Hepatitis B	Not Applicable	Terminated(Safety concerns fro... more >>m other studies.) Collapse <<	-	-
  NCT00034359	Hepatitis B, Chronic	Phase 2	Completed	-	Bulgaria ... more >> Clinic of Gastroenterology Sofia, Bulgaria Foundation of Gastroenterology Sofia, Bulgaria Former Yugoslavia Clinic Center of Serbia, Institute of Infectious Disease Belgrade, Former Yugoslavia Clinic of Novi Sad Novi Sad, Former Yugoslavia Collapse <<

• 更多
• 参考文献

• [1] Meusinger R. Doubling spectroscopy challenge. Anal Bioanal Chem. 2015 Nov;407(27):8169-72.

  [2] Schinazi RF, Massud I, et al. Selection and characterization of HIV-1 with a novel S68 deletion in reverse transcriptase. Antimicrob Agents Chemother. 2011 May;55(5):2054-60.